We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Development With Gene Expression You Can Count On

Bruker 2024 eBook cover: 'Drug Development with Gene Expression You Can Count On' with DNA helix graphic
Credit: Bruker

Check out our eBook to learn about the nCounter® Analysis System and how the nCounter technology can rapidly unlock actionable biological insights.

•    Learn the fundamentals of how the nCounter technology works and the benefits of using this technology in investigational drug discovery and development
•    Discover specific applications across drug development stages where nCounter technology has a particularly strong advantage
•    Read an example use case summary where nCounter gene expression profiling combined with GeoMx Digital Spatial Profiling introduced a new approach to identifying biomarkers in early stage lung cancer. The research team is exploring the potential of biomarkers to predict ICB treatment response in patients with early-stage NSCLC.

Begin exploring today!